Sichuan Haihui Pharmaceutical Co., Ltd.

Strive for progress, protect all beings

Sichuan haihui pharmaceutical co., LTD., a wholly-owned subsidiary of yangzijiang pharmaceutical group, is an important strategic production base of yangzijiang distribution in southwest China. It is a comprehensive pharmaceutical enterprise integrating research, development, production and sales of chemical drugs and medical instruments. The company covers a total area of about 500 mu. Construction started in September 2013. In March 2017, the first phase of the project was officially put into use, and in the same year, the GMP certification for small-volume injection workshop No. 1 was completed. In August 2018, the solid preparation workshop obtained GMP certificate. In 2020, Haihui Pharmaceutical has been awarded the second-level safety standardization enterprise, the AAAA level model harmonious labor relationship unit in Chengdu, the national high-tech enterprise and the occupational health demonstration unit in Chengdu.

The company has always been adhering to the group's corporate mission of "seeking progress, protecting all sentient beings", adhere to the core values of "high quality, benefit the people, innovation and perfection", make full use of the advantages of scientific research, talents and information in the southwest region, strengthen the research and development of new products, improve product quality, accelerate the promotion of enterprise innovation and development and variety transfer. During the 14th Five-Year Period, Haihui Pharmaceutical will achieve rapid development with the support of the Group and its own efforts.